Last updated 54 days ago
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
440 patients around the world
Available in Spain, Brazil, Argentina, United States, Mexico, Panama
GlaxoSmithKline
1Research sites
440Patients around the world
This study is for people with
Interstitial Lung Disease
Requirements for the patient
From 18 Years
All Gender
Medical requirements
StudyBEconneCTD-ILD
SponsorGlaxoSmithKline
Conditions
Interstitial Lung Disease
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06572384
